AB

Anke Babu Ananda

Director Director DIN 07951830
DIN 07951830 First appointment Sep 2017 Primary industry General Business
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 0 active board seats
Past companies 1 historical roles
Total affiliations 1 Since Sep 2017
Shareholding value Locked Premium profile

About Anke Babu Ananda

Data last updated:

Anke Babu Ananda has 9 years in corporate governance. Formerly with 1 company, such as Ayati Pharma Private Limited. Engaged in General Business. Contributes to corporate operations.

DIN 07951830
Primary Designation Director
First Appointment 28 Sep 2017
Oldest Company Age Not Provided

Current companies

No current companies available.

Previous companies

CompanyDesignationAppointmentFoundedStatus
Ayati Pharma Private Limited U74999MH2017PTC300240
Director28 Sep 20172017Active

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Ayati Pharma Private Limited
Premium access

Shareholding and investment profile for Anke Babu Ananda

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Anke Babu Ananda

Anke Babu Ananda has 9 years in corporate governance. Formerly with 1 company, such as Ayati Pharma Private Limited. Engaged in General Business. Contributes to corporate operations.

Anke Babu Ananda is associated with 0 companies as a director.

Anke Babu Ananda has expertise in General Business.

Anke Babu Ananda has 9 years in corporate governance.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available